79 research outputs found
HE4 in the differential diagnosis of ovarian masses
Ovarian masses, a common finding among pre- and post-menopausal women, can be benign or malignant. Ovarian cancer is the leading cause of death from gynecologic malignancy among women living in industrialized countries. According to the current guidelines, measurement of CA125 tumor marker remains the gold standard in the management of ovarian cancer. Recently, HE4 has been proposed as emerging biomarker in the differential diagnosis of adnexal masses and in the early diagnosis of ovarian cancer. Discrimination of benign and malignant ovarian tumors is very important for correct patient referral to institutions specializing in care and management of ovarian cancer. Tumor markers CA125 and HE4 are currently incorporated into the Risk of Ovarian Malignancy Algorithm” (ROMA) with menopausal status for discerning malignant from benign pelvic masses. The availability of a good biomarker such as HE4, closely associated with the differential and early diagnosis of ovarian cancer, could reduce medical costs related to more expensive diagnostic procedures. Finally, it is important to note that HE4 identifies platinum non-responders thus enabling a switch to second line chemotherapy and improved survival
Low 25-OH vitamin D levels at time of diagnosis and recurrence of ovarian cancer.
The objective of this study was to evaluate the correlation between 25-OH vitamin D and ovarian cancer as a diagnostic marker or recurrence disease marker. We studied the following: (1) 61 women without gynecologic diseases, (2) 45 women affected by benign ovarian disease, (3) 46 women with recent diagnosis of ovarian cancer, (4) 26 follow-up women with recurrent ovarian cancer, and (5) 32 follow-up women with stable ovarian cancer. The 25-OH vitamin D was quantified with LUMIPULSE® G 25-OH vitamin D on LUMIPULSE® G 1200 (Fujirebio, Japan). As a threshold value, identified by ROC curve analysis, 20.2 ng/mL (sensitivity 73.3 %, specificity 84 %) was chosen corresponding to the limit between sufficient and insufficient 25-OH vitamin D according to the WHO. Low 25-OH vitamin D levels were observed in 26 % of women without gynecologic diseases, in 80 % of women with recent diagnosis of ovarian cancer and in 24 % women affected by benign ovarian diseases (p < 0.001). The follow-up study showed an insufficient level of 25-OH vitamin D in 73 % women with recurrent ovarian cancer and in 47 % women with stable ovarian cancer (p < 0.0003). This study showed that patients with ovarian cancer are often insufficient in 25-OH vitamin D compared to women with benign ovarian diseases. The women with recurrent ovarian cancer presented more often low levels compared to women with stable ovarian cancer. This study suggests that 25-OH vitamin D, due to its antiproliferative properties, can be a good marker for ovarian cancer also
Evaluation of Water Variables in No-Take Zone of Ustica Marine Protected Area (Southern Tyrrhenian Sea)
ABSTRACT In this research, the seasonal fluctuations of the main water variables in the no-take area (A zone) of the Ustica MPA were investigated. This study aims to monitor the water quality of the Ustica MPA, to analyze all the hydrological parameters useful to the physical-chemical characterization of water and to use TRIX index to characterize the trophic level of the coastal marine area. The final results shown that Ustica is an area of relevant environmental and ecological value and is a good example of a Marine Protected Area, which is not excessively affected by the human presence even during the touristic season. This study represents the first records based on well-organized protocol in order to assess water column characteristics of the studied area. This paper could be used as a reference document for future studies regarding the same or similar areas
Role of galectin-3 combined with multi-detector contrast enhanced computed tomography in predicting disease recurrence in patients with ovarian cancer
Galectin-3 (Gal-3) is an endogenous β-galactoside-binding lectin, playing an important role in the pathogenesis
of multiple malignancies. Aim of the study was to evaluate in a group of patients treated for ovarian cancer (EOC),
the role of Gal-3 combined with multi-detector contrast-enhanced computed tomography (MDCT), as predictor of
recurrence disease. Seventeen follow-up patients with recurrent ovarian cancer and 13 follow-up patients with stable
ovarian disease, who performed MDCT at one-year follow-up after cytoreductive treatment, were enrolled. Serum
Gal-3 concentrations were determined by using ELISA method. Twenty healthy controls were included in the analysis.
Two radiologist blinded to patients status, reviewed MDCT exams, recording the following signs of disease recurrence:
local tumor spread, enlarged lymph-nodes, carcinomatosis implants and metastases. We calculated the respective
threshold values of Gal- 3 identified by ROC curve analysis for each imaging findings related to disease recurrence
: lymphoadenopathies 92.45 ng/ml (AUC: 0.81, Se=91% Spe=73%), carcinomatosis 85.95 ng/ml (AUC:0.93 Se=
93.7%, Spe=92.8%), local tumor spread 99.05 (AUC:0.90, Se=100%, Spe=73% ) and metastasis 99.05ng/ml (AUC
:0,78, Se=100% , Spe=70%). A significant correlation between high Gal-3 serum levels and presence of local tumor
spread (n=11/17, p:0.001), carcinomatosis (n=16/17, p:0.00), lymphoadenopathies (n=15/17, p:0.00) and metastasis
(n=11/17, p:0.003) related with recurrence disease was observed. Patients with recurrence of ovarian cancer presents
higher Gal-3 values compared to women with stable diseases. Gal-3 combined to CECT should be used to improve
the monitoring of EOC patients
The role of ultrafast sequences MRI in the diagnostic evaluation and in the therapeutic option in female stress urinary incontinence.
Abstract 58
Role of fetal MRI in the evaluation of isolated and non-isolated corpus callosum dysgenesis: results of a cross-sectional study
PURPOSE:
The aims of this study were to characterize isolated and non-isolated forms of corpus callosum dysgenesis (CCD) at fetal magnetic resonance imaging (MRI) and to identify early predictors of associated anomalies.
METHODS:
We retrospectively analyzed 104 fetuses with CCD undergoing MRI between 2006 and 2016. Corpus callosum, cavum septi pellucidi, biometry, presence of ventriculomegaly, gyration anomalies, cranio-encephalic abnormalities and body malformations were evaluated. Results of genetic tests were also recorded.
RESULTS:
At MRI, isolated CCD was 26.9%, the rest being associated to other abnormalities. In the isolated group, median gestational age at MRI was lower in complete agenesis than in hypoplasia (22 vs 28 weeks). In the group with additional findings, cortical dysplasia was the most frequently associated feature (P = 0.008), with a more frequent occurrence in complete agenesis (70%) versus other forms; mesial frontal lobes were more often involved than other cortical regions (P = 0.006), with polymicrogyria as the most frequent cortical malformation (40%). Multivariate analysis confirmed the association between complete agenesis and cortical dysplasia (odds ratio = 7.29, 95% confidence interval 1.51-35.21).
CONCLUSIONS:
CCD is often complicated by other intra-cranial and extra-cranial findings (cortical dysplasias as the most prevalent) that significantly affect the postnatal prognosis. The present study showed CCD with associated anomalies as more frequent than isolated (73.1%). In isolated forms, severe ventriculomegaly was a reliable herald of future appearance of associated features
CAESAR models for developmental toxicity
<p>Abstract</p> <p>Background</p> <p>The new REACH legislation requires assessment of a large number of chemicals in the European market for several endpoints. Developmental toxicity is one of the most difficult endpoints to assess, on account of the complexity, length and costs of experiments. Following the encouragement of QSAR (<it>in silico</it>) methods provided in the REACH itself, the CAESAR project has developed several models.</p> <p>Results</p> <p>Two QSAR models for developmental toxicity have been developed, using different statistical/mathematical methods. Both models performed well. The first makes a classification based on a random forest algorithm, while the second is based on an adaptive fuzzy partition algorithm. The first model has been implemented and inserted into the CAESAR on-line application, which is java-based software that allows everyone to freely use the models.</p> <p>Conclusions</p> <p>The CAESAR QSAR models have been developed with the aim to minimize false negatives in order to make them more usable for REACH. The CAESAR on-line application ensures that both industry and regulators can easily access and use the developmental toxicity model (as well as the models for the other four endpoints).</p
Broad Band Observations of Gravitationally Lensed Blazar during a Gamma-Ray Outburst
QSO B0218+357 is a gravitationally lensed blazar located at a
cosmological redshift of 0.944. In July 2014 a GeV flare was observed by
Fermi-LAT, triggering follow-up observations with the MAGIC telescopes
at energies above 100 GeV. The MAGIC observations at the expected time
of arrival of the trailing component resulted in the first detection of
QSO B0218+ 357 in Very-High-Energy (VHE, >100 GeV) gamma rays. We
report here the observed multiwavelength emission during the 2014 flare.</p
Broad Band Observations of Gravitationally Lensed Blazar during a Gamma-Ray Outburst
QSO B0218+357 is a gravitationally lensed blazar located at a cosmological redshift of 0.944. In July 2014 a GeV flare was observed by Fermi-LAT, triggering follow-up observations with the MAGIC telescopes at energies above 100 GeV. The MAGIC observations at the expected time of arrival of the trailing component resulted in the first detection of QSO B0218+357 in Very-High-Energy (VHE, >100 GeV) gamma rays. We report here the observed multiwavelength emission during the 2014 flare
- …